Pharmacokinetics of Atazanavir in Special Populations
Conditions:  HIV/AIDS;  Tuberculosis Interventions:  Drug: Atazanavir 300mg/ Ritonavir 100 mg once daily;  Drug: Atazanavir 250 mg / ritonavir 80 mg Sponsors:  University of Liverpool;  Infectious Diseases Institute, Makerere University College of Health Sciences;  Joint Clinical Research Centre- Kampala;  Desmond Tutu HIV Foundation, Cape Town;  University of Cape Town Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials